Phenylhydrazines
Aobchem (3-Ethyl-2-fluoro-5-methylphenyl)boronic acid | 97% | C9H12BFO2 | 250mg
(3-Ethyl-2-fluoro-5-methylphenyl)boronic acid | 97% | C9H12BFO2 | 250mg
Aobchem (2-Bromo-6-chloro-3-methylphenyl)(methyl)sulfane | ≥97% | CAS 2635937-31-2 | C8H8BrClS | 10g
(2-Bromo-6-chloro-3-methylphenyl)(methyl)sulfane | ≥97% | CAS 2635937-31-2 | C8H8BrClS | 10g
Aobchem 4-(Hydroxymethyl)-3-methylphenol | ≥95% | CAS 22574-58-9 | C8H10O2 | 250mg
4-(Hydroxymethyl)-3-methylphenol | ≥95% | CAS 22574-58-9 | C8H10O2 | 250mg
Aobchem 2-(4-Hydroxyphenyl)benzaldehyde | ≥97% | CAS 400747-55-9 | C13H10O2 | 10g
2-(4-Hydroxyphenyl)benzaldehyde | ≥97% | CAS 400747-55-9 | C13H10O2 | 10g
Accela Chembio Inc 3-fluorophenylhydrazine Hydrochloride | 25g | 2924-16-5 | MFCD00012934 | 97+% | Shelf Life: 1260 Days | Light Sensitive/moisture Sensitive/+4
3-fluorophenylhydrazine Hydrochloride | 25g | 2924-16-5 | MFCD00012934 | 97+% | Shelf Life: 1260 Days | Light Sensitive/moisture Sensitive/+4
Aobchem (3-Bromo-2-chloro-5-methylphenyl)(methyl)sulfane | 97% | CAS 2707121-45-5 | C8H8BrClS | 5g
(3-Bromo-2-chloro-5-methylphenyl)(methyl)sulfane | 97% | CAS 2707121-45-5 | C8H8BrClS | 5g
Aobchem 3-Chloro-2-fluoro-6-methylphenol | 97% | CAS 1805640-67-8 | C7H6ClFO | 500mg
3-Chloro-2-fluoro-6-methylphenol | 97% | CAS 1805640-67-8 | C7H6ClFO | 500mg
Aobchem 4-Chloro-2-fluoro-5-methylphenylboronic acid | ≥97% | CAS 325786-09-2 | C7H7BClFO2 | 25g
4-Chloro-2-fluoro-5-methylphenylboronic acid | ≥97% | CAS 325786-09-2 | C7H7BClFO2 | 25g
Aobchem 2-Chloro-5-fluoro-3-methylphenol | ≥95% | CAS 1805455-85-9 | C7H6ClFO | 500mg
2-Chloro-5-fluoro-3-methylphenol | ≥95% | CAS 1805455-85-9 | C7H6ClFO | 500mg
Aobchem 2-Fluoro-3-formyl-4-methylphenylboronic acid | 97% | C8H8BFO3 | 500mg
2-Fluoro-3-formyl-4-methylphenylboronic acid | 97% | C8H8BFO3 | 500mg
Aobchem (2-Bromo-6-chloro-4-methylphenyl)(methyl)sulfane | 95% | CAS 2710534-06-6 | C8H8BrClS | 25g
(2-Bromo-6-chloro-4-methylphenyl)(methyl)sulfane | 95% | CAS 2710534-06-6 | C8H8BrClS | 25g
Medchemexpress LLC 2-Methyl-1,2,5,6-tetrahydro-3H-pyrrolo[3,2,1-ij]quinazolin-3-imine hydrochloride | C11H14ClN3 | 5 MG
JBSNF-000028 hydrochloride is an orally active, small molecule inhibitor of tricyclic nicotinamide N-methyltransferase (NNMT) with IC50 values of 33 nM for human NNMT. It effectively reduces endogenous MNA levels in U2OS osteosarcoma cells with an EC50 of 2.5 μM. This compound has demonstrated significant anti-obesity and anti-diabetic activities in diet-induced obesity models.
- Inhibits NNMT activity with an EC50 of 2.5 μM in U2OS cells
- Shows no cytotoxicity against HepG2 cells at 10-100 μM
- Improves glucose and lipid handling in mice with diet-induced obesity
- Improves glucose tolerance in NNMT knockout mice with diet-induced obesity
- Used for studying metabolic diseases such as obesity, type 2 diabetes, and non-alcoholic fatty liver disease
Aobchem Ethyl 2-(4-fluoro-3-methylphenyl)-2-oxoacetate | ≥95% | CAS 732251-71-7 | C11H11FO3 | 5g
Ethyl 2-(4-fluoro-3-methylphenyl)-2-oxoacetate | ≥95% | CAS 732251-71-7 | C11H11FO3 | 5g
Aobchem (5-Bromo-2-fluoro-3-methylphenyl)(4-methylpiperazin-1-yl)methanone | ≥95% | CAS 2635937-17-4 | C13H16BrFN2O | 1g
(5-Bromo-2-fluoro-3-methylphenyl)(4-methylpiperazin-1-yl)methanone | ≥95% | CAS 2635937-17-4 | C13H16BrFN2O | 1g
Medchemexpress LLC Blarcamesine hydrochloride | 195615-84-0 | 99.87% | 317.85 | 10 MG
Blarcamesine hydrochloride, also known as Anavex 2-73, is a Sigma-1 Receptor agonist. This compound is widely utilized in laboratory research, particularly for studies related to neurological and neurodegenerative diseases. It has also been explored in clinical trials for conditions such as breast cancer.
- Acts as a Sigma-1 Receptor agonist with an IC50 of 860 nM
- Exhibits a purity of 99.87%
- Presents as a white to off-white solid
- Offers solubility in H2O and DMSO
- Suitable for various in vitro and in vivo research applications